Related Experiment Video
Updated: Jul 9, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Nuclear factor-kappa B: from clone to clinic
Kwang Seok Ahn1, Gautam Sethi, Bharat B Aggarwal
1Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Insights
Nuclear factor kappaB (NF-kappaB) is a key regulator of genes involved in inflammation and cell survival. Its aberrant activation is linked to various diseases, including cancer, driving research into therapeutic inhibitors.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- Nuclear factor kappaB (NF-kappaB) is a transcription factor initially identified in B cells.
- In its resting state, NF-kappaB resides in the cytoplasm.
- Upon activation by stimuli like inflammation or stress, it translocates to the nucleus.
Purpose of the Study:
- To review the role of NF-kappaB in various biological processes.
- To highlight the association of NF-kappaB activation with diverse inflammatory diseases and cancer.
- To discuss the diagnostic, prognostic, and therapeutic potential of NF-kappaB.
Main Methods:
- Literature review of studies on NF-kappaB.
- Analysis of NF-kappaB's role in gene regulation.
- Examination of NF-kappaB's involvement in disease pathogenesis.
Main Results:
- NF-kappaB upregulates over 400 genes related to inflammation, cell survival, proliferation, invasion, and angiogenesis.
- Constitutive NF-kappaB activation correlates with cancer progression, survival, and resistance to therapy.
- NF-kappaB has demonstrated diagnostic and prognostic value in several conditions.
Conclusions:
- NF-kappaB plays a critical role in cellular responses and disease development.
- Targeting NF-kappaB is a promising therapeutic strategy for inflammatory diseases and cancer.
- NF-kappaB research has rapidly progressed from basic discovery to clinical applications.
Abstract:
Nuclear transcription factor kappaB (NF-kappaB) was first discovered in 1986 in the nucleus of the B cell as an enhancer in the kappa immunoglobulin chain. However, this factor has identified in the cytoplasm in the resting state. When activated in response to inflammatory stimuli, carcinogens, stress, ionizing radiation, and growth factors; NF-kappaB translocates to the nucleus where it upregulates the expression of over 400 different gene products linked with inflammation, cell survival, proliferation, invasion, and angiogenesis. The activation of NF-kappaB has now been linked with a variety of inflammatory diseases, including cancer and pulmonary, autoimmune, skin, neurodegenerative, and cardiovascular disorders. Indeed, constitutive NF-kappaB activation frequently correlates with the proliferation, survival, chemoresistance, radioresistance, and progression of various cancers. Hence, NF-kappaB has both diagnostic and prognostic applications. In addition, pharmaceutical companies are aggressively pursuing development of inhibitors of NF-kappaB with therapeutic potential. Thus within last decades this transcription factor, discovered serendipitously, has moved from "clone to clinic".
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors
Methods of Nuclear Reprogramming
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Introduction to Nuclear Reprogramming
General Transcription Factors

